BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
ERBB2
,
T cell receptor signaling pathway
,
Lung cancer
,
Adipose tissue
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
intellectual property
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Multisystem Complex Disorders
OMIM - Disorder of brain
OMIM - Developmental disorders
OMIM - Developmental delay
OMIM - Optic atrophy
Explore Curated Studies Results
Literature
Most Relevant Literature
The role of intellectual property rights in treatment access: challenges and solutions.
International intellectual property strategies for therapeutic antibodies.
India must respect intellectual property rights, report says.
The new patent regime and disease priorities in India.
Recalibrating intellectual property rights to enhance translational research collaborations.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Crossover Study of the Safety and PK Properties of Proellex®
Computerized Testing System for Measuring Motor and Sensory Integrative Functions in Intellectual Di…
A Family-Based Weight Loss Intervention for Youth With Intellectual Disability
National Stigma Survey About Mental Illness, Intellectual Disability and Homelessness in Spain
BEhavioral Health Stratified Treatment (BEST) Study for Youth With Intellectual and/or Developmental…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ